✦ LIBER ✦

Proof of efficacy and safety

✍ Scribed by William E. Jones

Book ID: 114258551
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 90 KB
Volume: 21
Category: Article
ISSN: 0737-0806
DOI: 10.1016/s0737-0806(01)70089-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The ‘experimental stable’ of the BCG vac

The ‘experimental stable’ of the BCG vaccine: safety, efficacy, proof, and standards, 1921–1933

✍ Christian Bonah 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 716 KB

Safety and Efficacy of Vagus Nerve Stimu

Safety and Efficacy of Vagus Nerve Stimulation in Fibromyalgia: A Phase I/II Proof of Concept Trial

✍ Gudrun Lange; Malvin N. Janal; Allen Maniker; Jennifer FitzGibbons; Malusha Fobl 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Preliminary Assessment of Safety and Eff

Preliminary Assessment of Safety and Efficacy in Proof-of-Concept, Randomized Clinical Trial of Tanezumab for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

✍ Nickel, J. Curtis; Atkinson, Gary; Krieger, John N.; Mills, Ian W.; Pontari, Mic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 266 KB

276 PRELIMINARY EFFICACY AND SAFETY OF R

276 PRELIMINARY EFFICACY AND SAFETY OF REPEATED ORAL DOSES OF NCX-1000 FOR THE TREATMENT OF PORTAL HYPERTENSION. A DOUBLE-BLIND, PROOF OF CONCEPT, DOSE ESCALATING STUDY

✍ J. Turnes; S. Raffa; J.G. Abraldes; J.C. Garcia-Pagan; C. Gagnon; J. Spenard; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

MLN3897 plus methotrexate in patients wi

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study

✍ Clarissa E. Vergunst; Danielle M. Gerlag; Lisa von Moltke; Michael Karol; Tim Wy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 3 views

## Abstract ## Objective To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX). ## Methods In this phase IIa, proof‐of‐concept study, patients meeting the

Echinacea—Proof of efficacy

✍ E. Schlueren 📂 Article 📅 1987 🏛 Harcourt Health Sciences 🌐 English ⚖ 59 KB